Neuro Insight

by Olea Medical S.A.S.  · Based in France → — Transforming Standards
Neurology Neurosurgery Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Neuro INSIGHT is an advanced neuroimaging MRI solution designed to transform diagnostic standards and expand access to neuroradiology expertise. It provides a dedicated environment for radiologists to deliver optimal results at every stage of diagnostic and follow-up evaluations for patients with brain disorders.

Through automated analysis, Neuro INSIGHT streamlines radiologists’ workflow, assisting in tackling a wide range of brain conditions by providing detailed qualitative and quantitative parameters needed to characterize intracranial abnormalities such as cerebral tumors, neurodegenerative diseases, and inflammatory disorders.

It enables radiologists to track patients longitudinally over time by automatically detecting and highlighting visible changes, helping evaluate disease progression or response to therapies. By optimizing workflows, reducing cognitive load, and automating routine analyses, Neuro INSIGHT improves diagnostic standardization and the speed of clinical decision-making, ultimately enhancing patient care.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated analysis of neurological MRI images
  • Longitudinal tracking of brain pathologies and therapy response
  • Automatic detection and highlighting of visible changes over time
  • Provides detailed qualitative and quantitative parameters for intracranial abnormalities
  • Streamlines radiologists' workflow and reduces cognitive load
  • Offers diagnostic guidance and assisted performance
  • Improves standardization of diagnoses
  • Accelerates clinical decision-making
  • Web-based access, no installation required on reading station
  • Vendor-agnostic standard PACS and RIS integrations

Use Cases

  • Initial diagnosis of neurological disorders
  • Characterization of cerebral tumors
  • Assessment of neurodegenerative diseases
  • Evaluation of inflammatory brain disorders
  • Longitudinal monitoring of brain pathologies
  • Tracking patient response to new therapies

What Physicians Need to Know

Stroke Detection Speed
Automatically generates stroke maps in a matter of seconds, significantly reducing image analysis time and accelerating patient care in stroke emergencies. The neurovascular module provides rapid, automated analysis of CT and MRI scans to compute key metrics for time-sensitive decisions.
Brain MRI/CT Analysis
Offers automated analysis for a wide range of brain conditions, providing detailed qualitative and quantitative parameters to characterize intracranial abnormalities like cerebral tumors, neurodegenerative diseases, and inflammatory disorders. It supports diffusion-perfusion analysis with mismatch assessment, DWI-FLAIR volume mismatch for infarct dating, and advanced FLAIR outputs. The solution also includes CT perfusion mapping with mismatch volume extraction and a 3D deep learning algorithm for brain extraction. It enables longitudinal tracking of patients by automatically detecting and highlighting visible changes over time.
Neurodegenerative Disease Screening
Assists in tackling neurodegenerative diseases by providing detailed qualitative and quantitative parameters. Through a partnership with Cortechs.ai, NeuroQuant is integrated into Olea Sphere, offering automatic and consistent measurements of brain structures from 3D T1 MRI images to quantify brain volume loss and assess neurodegeneration.
Large Vessel Occlusion Detection
Enables quick triage of large vessel occlusions (LVOs) and hemorrhages in seconds. It supports LVO detection in the anterior circulation (Distal ICA, M1 & Proximal M2) for CT imaging. AI-driven solutions provide comprehensive neurovascular analysis for both CT and MRI, designed for LVO detection.
Triage Prioritization Speed
Optimizes stroke case management by providing instant information and prioritizing clinical cases in a timely manner. AI-driven solutions enhance efficiency and diagnostic accuracy, enabling automated triage and prioritization to improve the speed of clinical decision-making.
ASPECTS Score Automation
Includes AI-based ASPECTS hypodensity probability heat maps for CT imaging. The e-STROKE SUITE, a collaboration with Brainomix, fully automates and standardizes the ASPECTS score, measuring ischemic lesion volumes and assessing non-contrast CT scans for hypodensity with a heat map. This automation improves the uniformity and accuracy of ASPECTS scoring.
Mobile Notification System
Features a dedicated mobile application for real-time alerts, notifications, and patient image overview. Automated, structured, and customizable reports for CT and MRI can be exported with mobile app notifications and visualization of key findings. A partnership with Pulsara offers mobile applications for real-time communication, chat, videoconferencing, and secure medical data sharing among stroke care teams.
Physician Tip

Neuro Insight streamlines complex neuroimaging analysis, allowing for faster and more standardized interpretation of MRI and CT scans in neurological disorders, particularly stroke. Leverage its automated reporting and mobile notifications for efficient communication and multidisciplinary collaboration. The longitudinal analysis feature is crucial for tracking disease progression and treatment response. While the tool provides advanced analytical support, always integrate its findings with comprehensive patient clinical information and your professional judgment for final diagnostic decisions, as it is intended to assist, not diagnose.

Neuro Insight is designed for vendor-agnostic integration with standard PACS and RIS systems, ensuring compatibility across various imaging environments. Its web-based access and imaging viewer allow for flexible deployment without local installation. The solution also supports automated report export to PACS and email, and integrates with mobile applications for enhanced workflow and communication.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-based (web access), thin client
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Neuro Insight V1.0 is an image processing solution intended to assist appropriately trained medical professionals in their analysis workflow on neurological MRI images. It is composed of an image processing application package (NeuroPro) and an optional user interface (Neuro Synchronizer). The device is not intended to be used as a standalone diagnostic device and should not be used as the sole basis for patient management decisions. The results are intended to be used in conjunction with other patient information and professional judgment.
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Neuro Insight

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Olea Medical
Neuro INSIGHT - Olea Medical
Neuro INSIGHT is an MRI neuroimaging solution designed to assist radiologists in diagnosing and monitoring neurological disorders by providing automated analysis, streamlining workflows, and enabling longitudinal tracking of brain pathologies.
2024-05
Olea Medical
Olea & Pulsara Unveil Groundbreaking Mobile Apps to Revolutionize Neurovascular Care
Olea Medical partnered with Pulsara to launch mobile applications that enhance real-time coordination and communication for stroke care teams, aiming to streamline patient pathways and improve outcomes in neurovascular care.
unknown
ITN Online
QT Imaging, Olea Medical Introduce New Viewer for Integrated, Multimodality Breast Imaging
QT Imaging and Olea Medical collaborated to launch the QTI Imaging-Olea Viewer, a unified platform for viewing multiple breast imaging modalities, aiming to simplify correlation of breast imaging and support future AI/ML integration.
2026-04
QT Imaging Holdings, Inc.
QT Imaging Announces Collaboration with Olea Medical to Advance Visualization and Quantitative Analytics for Its Cloud Imaging Platform
QT Imaging announced a collaboration with Olea Medical to integrate Olea's advanced visualization, quantitative analytics, and AI-ready imaging technologies into QT Imaging's Cloud SaaS Platform for breast imaging.
2026-01
FDA
510(k) Premarket Notification - FDA
This FDA 510(k) summary details Olea Medical's Neuro Insight V1.0, an image processing solution intended to assist medical professionals in analyzing neurological MRI images, which was found substantially equivalent to the Olea Sphere V3.0 software.
2025-07
X-ray Interpreter
Neuro Insight V1.0 | FDA Radiology AI Device
Neuro Insight V1.0 by Olea Medical S.A.S. is an advanced image processing system for radiological applications, designed to enhance insights from medical images for neurological assessments.
2025-07
Canon Medical
OLEA VISION TAKES THE LEAD IN MRI POST-PROCESSING WITH FORTY NEW AND UNIQUE APPLICATIONS - Canon Medical
Canon Medical Systems Europe and Olea Medical collaborated on a software upgrade for Canon's MRI systems, introducing 40 new applications in Olea Vision to enable faster, more accurate, and cost-effective diagnoses.
2018-05
HealthManagement.org
Olea Sphere Medical Imaging Software is Granted USFDA Approval
Olea Medical received FDA 510(k) clearance for Olea Sphere medical imaging enterprise software package version 2.3, which includes a Bayesian post-processing algorithm and T1 mapping plug-in, enhancing functional and dynamic imaging analysis.
2014-01

Videos

Product demos, reviews, and walkthroughs for Neuro Insight.

View all on YouTube

Frequently Asked Questions

Neuro Insight V1.0 is an image processing solution designed to assist medical professionals in analyzing neurological MRI images, providing visualization and manipulation tools. It aims to enhance workflow efficiency by automating routine tasks and streamlining clinical decision-making, though it is not a standalone diagnostic device.
As an image processing solution, Neuro Insight V1.0 is intended to assist medical professionals and is not a standalone diagnostic device. Healthcare AI tools, especially those assisting with clinical tasks, may fall under medical device regulations, requiring FDA review. Providers must ensure local validation of AI tools within their specific clinical context and adhere to robust data stewardship, privacy, and HIPAA compliance, establishing business associate agreements with vendors.
Neuro Insight V1.0 is an image processing solution intended to assist, not to be used as the sole basis for patient management decisions. General AI in neurology faces challenges like potential biases in algorithms, lack of interpretability, and the need for continuous research to refine accuracy. AI tools, while excellent at pattern identification, are not always accurate and struggle with the nuanced context, history, or patient interaction that human neurologists provide.
Alternatives include traditional human interpretation of neurological MRI images, often augmented by other clinical decision support systems. While AI can offer speed and detect subtle patterns, human neurologists provide holistic interpretation, empathy, and contextual judgment that AI cannot replicate. Specialized clinical decision support systems and general-purpose clinical Large Language Models (LLMs) can also assist with differential diagnosis and literature review.
Pricing models for diagnostic AI often include fixed costs, consumption-based models (per patient, per test), or customized solutions. Factors influencing cost include the scope and complexity of the AI project, data quality and processing requirements, and the level of customization. Hybrid models combining a base fee with variable components are also gaining traction, often aligning with reimbursement structures.
Effective implementation of healthcare AI requires adequate training and ongoing support for clinical users to ensure proper understanding and utilization within workflows. Vendors typically offer training programs and continuous support for technical issues, updates, and performance optimization.
AI technology in healthcare is rapidly evolving, with continuous research aiming to refine algorithms and improve diagnostic accuracy. Vendors typically have a roadmap for future enhancements, including new features and expanded capabilities, which should be clearly communicated to users along with any necessary re-validation.
Ethical considerations for healthcare AI include ensuring fairness, addressing potential algorithmic biases, maintaining transparency in AI use, and establishing clear accountability for AI-derived insights. Patient consent for AI use and robust protection of sensitive health information are also paramount.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Paid
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
Per-test pricing
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.